VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATIONRichard J. Jones, Rein Saral, Louise B. Grochow et al.|Transplantation|1987Cited by 914
Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein–Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros ExpressionRichard J. Jones, Robert Z. Orlowski|Clinical Cancer Research|2016Cited by 48
HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphomaRichard J. Jones, Robert Z. Orlowski|Blood|2011Cited by 39
The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1Richard J. Jones, Robert Z. Orlowski|Journal of Pharmacology and Experimental Therapeutics|2013Cited by 26
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLNour Sabiha Naji, Theodoros Karantanos, Taha Ahmedna et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1